Platform for the Prospective Mother-child Study of the Determinants of Neurodevelopmental Disorders

RecruitingOBSERVATIONAL
Enrollment

6,300

Participants

Timeline

Start Date

April 19, 2023

Primary Completion Date

March 31, 2034

Study Completion Date

March 31, 2034

Conditions
Autism Spectrum DisorderNeurodevelopmental Disorders
Interventions
OTHER

Questionnaires

Parents will be asked to complete online self-questionnaires. These questionnaires will provide essential information on medical data, child development, lifestyle habits, nutritional habits, environmental exposures, and family social characteristics.

OTHER

Biospecimen collection

urine, hair, nails, baby tooth, stool, blood, umbilical cord blood, placenta

OTHER

Neurodevelopmental assessment visit

"High-Risk Cohort : Clinical observations of the unborn child will be performed at 3 months, 6 months, 12 months, between 24 and 30 months, 36 months, and 72 months by psychologists or child psychiatrists in the participating hospitals. They will allow to evaluate the child's behaviors in the areas of communication and social interaction.~A video recording of the baby at 3 months of age will allow the analysis of the General Movements Assessment.~Low-Risk Cohort : linical observations of the unborn child will be performed at 72 months by psychologists or child psychiatrists in the participating hospitals."

OTHER

DNA collection

If genetic consultation is provided to the family as part of the routine care, the results will be collected and additional blood samples may be taken.

Trial Locations (1)

34 090

RECRUITING

CHU Montpellier, Montpellier

All Listed Sponsors
collaborator

University Hospital, Lille

OTHER

collaborator

Hospices Civils de Lyon

OTHER

collaborator

University Hospital of Saint-Etienne

OTHER

collaborator

University Hospital, Rouen

OTHER

collaborator

University Hospital, Toulouse

OTHER

collaborator

Hôpital le Vinatier

OTHER

lead

University Hospital, Montpellier

OTHER